Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study
Hui Shi, Fan Yang, Miaomiao Cao, Teng Xu, Peihao Zheng, Yuelu Guo, Guoai Su, Shaomei Feng, Ruiting Li, Rui Liu, Haidi Liu, Lixia Ma, Xiaoyan Ke, Kai Hu
Topics & Concepts
VenetoclaxDaratumumabMedicineOpen labelInternal medicineOncologyMultiple myelomaLenalidomideClinical trialLeukemiaChronic lymphocytic leukemiaAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and Treatment